Ginkgo Bioworks Holdings, Inc.(DNA)Earnings Date, History & Expected Move

Next report
Not scheduled

DNA has no upcoming report date in the calendar yet. It last reported on Nov 5, 2026; companies usually report every three months.

Next report
Not scheduled
Last reported Nov 5, 2026
EPS beat rate
64%
7 of 11 quarters (+1 not counted)
Avg move after earnings
±13.6%
Up 25% of the time · last 12
Options-implied move
—
No reliable options quote yet

EPS: Actual vs Estimate

Reported EPS against the consensus estimate, last 12 quarters.

Green beat or met, red missed, amber sources differ.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±13.6%).

Did the stock rise after good news?

The next-day move after each of its last 7 EPS beats and 4 misses.

When it beat expectations
7 reports
When it missed expectations
4 reports

In plain words: it beat expectations 7 times, but the stock still fell 4 of those 7 times.

Report by report
  • Nov '26
    Beat
    ▲ +13.4%
  • May '26
    Missed
    ▼ -13.5%
  • Feb '26
    Beat
    ▼ -30.5%
  • Nov '25
    Missed
    ▼ -20.8%
  • Aug '25
    Beat
    ▼ -8.7%
  • May '25
    Beat
    ▲ +14.7%
  • Feb '25
    Beat
    ▼ -11.5%
  • Nov '24
    Beat
    ▲ +2.5%
  • Aug '24
    Missed
    ▼ -5.6%
  • May '24
    Beat
    ▼ -17.3%
  • Feb '24
    Missed
    ▼ -15.1%

Clear beats and misses with a known reaction only. What counts as a beat

After an EPS beat
-5.3%
average next-day move · up 43% of 7 times
After an EPS miss
-13.8%
average next-day move · up 0% of 4 times

Why did DNA fall after beating earnings?

4 of DNA's last 11 reactions went against the EPS result. What stands out in each:

DNA beat EPS estimates in 7 quarters, and the stock still closed lower the next day 4 times. In 2 of the 4 where we have price data, the stock had already run up before the report.

  • Feb 26, 2026EPS beat +30.6%stock -30.5% next day
    • It opened 17.5% lower as soon as trading resumed.
  • Aug 7, 2025EPS beat +29.9%stock -8.7% next day
    • It had risen 24.7% in the 20 trading sessions before the report, so good news may already have been priced in.
    • It opened 4.4% higher, but sellers took over and it closed -8.7%.
  • Feb 25, 2025EPS beat +6.9%stock -11.5% next day
    • It opened 14.3% lower as soon as trading resumed.
  • May 9, 2024EPS beat +10.3%stock -17.3% next day
    • It had risen 6.9% in the final week before the report, so good news may already have been priced in.
    • It opened 13.4% lower as soon as trading resumed.

Patterns in estimates and prices, not confirmed causes: how we read them.

Was DNA's earnings move already priced in?

DNA's move in the month before each of its last 12 reports, against what it did after.

Avg move in the month before
+4.3%
last 12 reports
Higher before the report
58%
of the time
After a run-up of 3%+
Fell 80%
5 reports, avg -8.8%
After a drop of 3%+
Rose 20%
5 reports, avg -8.4%

How the run-up is measured (a move of 5% or more counts as large).

Before vs after each report

Grey: the month before each of the last 12 reports. Green or red: the day after.

Past reports only. How the run-up is measured

Does DNA hold its opening gap after earnings?

DNA's opening move after each report and where it closed that day.

In 12 reports DNA opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 12 times (25%), and fully reversed 2 times. Gaps up faded 3 of 5; gaps down recovered 0 of 7.

  • Nov 5, 2026Held
    Opened +2.0%, closed +13.4%
  • Aug 5, 2026Held
    Opened -2.6%, closed -9.3%
  • May 7, 2026Held
    Opened -16.2%, closed -13.5%
  • Feb 26, 2026Held
    Opened -17.5%, closed -30.5%
  • Nov 6, 2025Held
    Opened -8.9%, closed -20.8%
  • Aug 7, 2025Reversed
    Opened +4.4%, closed -8.7%
  • May 6, 2025Held
    Opened +5.9%, closed +14.7%
  • Feb 25, 2025Held
    Opened -14.3%, closed -11.5%

How gaps, fades and reversals are defined

What the history says

  • It fell after 4 of its 7 EPS beats (57%): beating estimates has not been enough on its own.

DNA earnings history

Last 12 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report dateTimeEPS est.EPS actualSurpriseRevenue surprise1-day move3-day move
Nov 5, 2026After close-$0.54-$0.48+11.1%+27.2%+13.35%—
Aug 5, 2026After close-$0.70-$0.73sources differ—-9.29%-18.36%
May 7, 2026After close-$1.34-$1.39-3.7%—-13.47%-19.19%
Feb 26, 2026After close-$1.11-$0.77+30.6%—-30.48%-31.00%
Nov 6, 2025After close-$1.24-$1.45-16.9%—-20.80%-25.13%
Aug 7, 2025After close-$1.57-$1.10+29.9%—-8.69%-14.12%
May 6, 2025After close-$1.77-$1.68+5.1%—+14.73%+20.31%
Feb 25, 2025After close-$1.30-$1.21+6.9%—-11.47%-19.92%
Nov 12, 2024After close-$3.32-$1.08+67.5%—+2.50%-24.08%
Aug 8, 2024After close-$3.12-$4.40-41.0%—-5.59%-1.75%
May 9, 2024After close-$3.20-$2.87+10.3%—-17.28%-6.20%
Feb 29, 2024After close-$2.80-$2.94-5.0%—-15.13%-24.34%

DNA Earnings FAQ

Answers computed from Ginkgo Bioworks Holdings, Inc.'s reported history

DNA has no upcoming report date in the calendar yet. It last reported on Nov 5, 2026; companies usually report every three months.

Over the last 11 quarters with a usable EPS surprise, DNA beat the consensus estimate 7 times (64%), missed 4 and landed in line 0. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.

Across its last 12 quarters with a measured reaction, DNA moved an average of ±13.6% in the first session after reporting. It closed higher 25% of the time; the largest gain was 14.7% and the largest drop -30.5%.

DNA fell in the first session after 4 of its last 7 EPS beats (57%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 4 of those falls where price data is available, the stock had already risen before the report.

Across its last 12 quarters with price data, DNA moved an average of +4.3% in the 20 trading sessions before reporting and was higher in 58% of them. After a run-up of 3% or more (5 quarters), it fell the next day 80% of the time, averaging -8.8%. After a drop of 3% or more (5 quarters), it rose the next day 20% of the time, averaging -8.4%. This describes past reports; it is not a forecast.

In 12 reports DNA opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 12 times (25%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.

How we calculate these numbers · DNA: 12 reported quarters, latest Nov 5, 2026. Information only, not investment advice.

Looking for more on DNA?

Price charts, forecast, fundamentals and risk pages for DNA are not on Tickzen yet. You can run a full stock analysis now.

Run the DNA Stock Analyzer